Search
Displaying results 671 to 676 of 676.
Infection Immunology
An infection can be seen as a fight between a microbe and our body’s defence mechanisms. The microbe is trying to multiply and disseminate, while the different components of our immune system will work together trying to stop this process. This is not an easy mission for our body because microbes have learned how to hide, evade or even destroy some of the components of the immune system as well as how to resist antibiotic treatment. The focus of our research is to understand the battle between microbes and our immune defences. If we know the different tricks and mechanisms employed by the microbes to breach our defences we will be able to design new strategies to counteract and disarm the attacking microorganisms.
Clinical Bioinformatics
The Department “Clinical Bioinformatics” is concerned with analyzing molecular information using computer-based methods such as machine learning, artificial intelligence, or other algorithms. Its focus lies on spatially and temporally resolved processes to help understand how bacteria, as producers of natural products, interact with humans and can trigger or even protect against disease. This department is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) .
Biosafety Level 3 Laboratory
Biological agents of risk group 3 (RG3) pose a constant global as well as national challenge because they cause severe illnesses in humans against which there are usually no effective preventive or treatment measures. Since these pathogens can only be handled in special biosafety level 3 (BSL3) laboratories, the modern BSL3 laboratories at the HZI provide a technology platform that is indispensable in today's infection research - only in this way can our scientists develop new therapies, prevention measures or diagnostic procedures against these pathogens.
Mouse Pathology
Histology is the science of tissues and pathology. In a sense, it is also the science of diseases and their pathogenesis. The major concern of histologists working in our service unit is helping other HZI researchers make this connection and work out the details of the relationship between histological changes at the tissue level and the infectious diseases they are studying.
Actinobacteria Metabolic Engineering
The growing resistance towards established antibiotics presents a serious problem especially with infectious diseases. The development of new drugs is mainly based on known molecules and mechanisms, which allows bacteria to assimilate rapidly. Hence, scientists are looking for novel drugs. At the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) , a site of the Helmholtz Centre for Infection Research (HZI) at Braunschweig, the researchers develop new pathways, by which they force actinomycetes to produce hitherto unknown compounds.
